Why This Pharma Boss Isn’t Chasing the Obesity Hype
Belen Garijo, the CEO of Merck KGaA, says focus on growth and innovation is key to the German group’s future.
European Stocks Close Higher After ECB Lowers Interest Rate
European stocks closed higher on Thursday with investors cheering the European Central Bank's rate cut announcement, and digesting a ...
Germany's Merck open to more M&A for its Life Science division
German science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May ...
DPA International on MSN1d
German science and tech giant Merck confirms full-year guidance
German science and technology giant Merck on Thursday said it is confident of returning to medium-term growth after a ...
InAVate1d
Midwich Group unveils new brand identity
The brand evolution will see Midwich Ltd (including Holdan, Invision, PSCo, Pulse Cinemas, and Square One), Midwich APAC, ...
Merck KGaA Cuts Medium-Term Healthcare, Life-Science Outlook but Lifts Electronics Guidance
Merck KGaA lowered its medium-term outlook for its healthcare and life-science segment due to China challenges and recent pipeline setbacks but raised its electronics forecast, citing strong ...
Merck KGaA Trims Health Care And Life Sciences Targets, Eyes M&A
Merck KGaA cut its mid-term sales growth target for its health-care division after a number of high-profile drug trial ...
Goldman Sachs Remains a Sell on Exelixis (EXEL)
In a report released yesterday, Chris Shibutani from Goldman Sachs maintained a Sell rating on Exelixis (EXEL – Research Report). The ...
UnitedHealth forecasts 2025 profit below Street estimates, shares fall
UnitedHealth Group provided a 2025 profit forecast below Wall Street estimates on Tuesday as it expects pressure across its ...